HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 61552Generated: October 29, 2026
1-Isopropylpiperazine → tert-butyl 5-(2-(3-(3-(4-isopropylpiperazin-1-yl)propanamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate
https://huagongshe.com/reaction/61552
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Isopropylpiperazine | HCID 78013 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | tert-butyl 5-(2-(3-(2-chloroacetamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate | HCID 56949464 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | tert-butyl 5-(2-(3-(3-(4-isopropylpiperazin-1-yl)propanamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate | HCID 59361908 | — |
Reaction Steps
A suspension of tert-butyl 5-(2-(3-(2-chloroacetamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate (112 mg, 0.223 mmol), 1-isopropylpiperazine (52 mg, 0.406 mmol), DIEA (51 mg, 0.402 mmol) in DMF (2 mL) was stirred at 75° C. for 4 h. The reaction mixture was cooled to RT and the residue was poured into ice-water. The resulting white solid was filtered and dried for several hours under high vacuum. The crude product was purified by prep TLC using CH2Cl2: MeOH, (9:1) as the mobile phase to afford tert-butyl 5-(2-(3-(3-(4-isopropylpiperazin-1-yl)propanamido)phenyl)quinazolin-4-ylamino)-1H-indazole-1-carboxylate. (60 mg, 0.094 mmol, 42%)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09440961B2 |
|---|
| Source dataset | uspto-grants-2016_09 |
|---|
| ORD ID | ord-37014d777d8440a7be659c1b839d18bb |
|---|
| Source note | uspto-grants-2016_09 |
|---|